glp-1 research papers and GIP: Mercodia products in the spotlight Issue 42: GLP-1 RA Drug

The SUMMIT trial demonstrated that treatment with tirzepatide reduced the risk of a composite of cardiovascular-related deaths or worsening heart failure, compared with placebo, and improved the health of patients with heart failure with preserved ejection fraction and obesity [147]

Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly

2022Tirzepatide once weekly for the treatment of obesity

The new program starts at $119, with a monthly cost of $199, and includes GLP-1 medication (if prescribed), access to Nooms GLP-1 Companion behavior and microhabits program, 24/7 messaging with doctors and care coordinators, one-on-one premium health coaching and home delivery of prescriptions